MedPath

Colby Pharmaceutical Company

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects

Phase 2
Completed
Conditions
Influenza
First Posted Date
2009-07-10
Last Posted Date
2011-02-14
Lead Sponsor
Colby Pharmaceutical Company
Target Recruit Count
472
Registration Number
NCT00936468

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

Phase 1
Completed
Conditions
Influenza
First Posted Date
2008-04-21
Last Posted Date
2010-03-17
Lead Sponsor
Colby Pharmaceutical Company
Target Recruit Count
128
Registration Number
NCT00662272
Locations
🇺🇸

Miami Research Associates, Miami, Florida, United States

🇺🇸

Johnson County Clin-Trials, Lenexa, Kansas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.